Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01704716
Title High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors St. Anna Kinderkrebsforschung
Indications

neuroblastoma

Therapies

Busulfan + Melphalan

Carboplatin + Cisplatin + Cyclophosphamide + Etoposide + Filgrastim

Cisplatin + Cyclophosphamide + Doxorubicin + Etoposide + Vincristine Sulfate

Dinutuximab beta

Aldesleukin + Dinutuximab beta

Carboplatin + Etoposide + Melphalan

Carboplatin + Cisplatin + Cyclophosphamide + Etoposide + Vincristine Sulfate

Age Groups: child | adult
Covered Countries


No variant requirements are available.